Mckesson Corp
MCKView Detailed Chart
683.110USD
-33.670-4.69%
Close 04/04, 16:00（ET）Quotes delayed by 15 min
88.80BMarket Cap
31.42P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-4.69%
5 Days
+2.24%
1 Month
+6.45%
6 Months
+40.72%
Year to Date
+19.86%
1 Year
+26.79%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
18
analysts
BUY
Current Rating
691.046
Target Price
1.16%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
150
Total
5
Median
7
Average
Company name
Ratings
Analysts
Mckesson Corp
MCK
18
Biogen Inc
BIIB
37
Amgen Inc
AMGN
33
Alnylam Pharmaceuticals Inc
ALNY
33
Gilead Sciences Inc
GILD
30
BioMarin Pharmaceutical Inc
BMRN
29
1
2
3
...
30
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Neutral
Indicators
Indicators
Value
Direction
MACD(12,26,9)
3.727
Buy
RSI(14)
60.012
Neutral
STOCH(KDJ)(9,3,3)
63.722
Sell
ATR(14)
15.427
High Vlolatility
CCI(14)
140.182
Buy
Williams %R
58.321
Sell
TRIX(12,20)
0.350
Sell
StochRSI(14)
0.000
Sell
Moving Average
Indicators
Value
Direction
MA5
688.092
Sell
MA10
676.176
Buy
MA20
665.838
Buy
MA50
633.268
Buy
MA100
614.349
Buy
MA200
580.703
Buy
News
More news coming soon, stay tuned...
Company
McKesson Corporation is a provider of diversified healthcare services. It is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.
Company codeMCK
CompanyMckesson Corp
CEOMr. Brian Scott Tyler, Ph.D.
Websitehttps://www.mckesson.com/
